82 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
not been disclosed therein, and (C) if elected as a Director, will comply with all applicable corporate governance, conflict of interest
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
Act") regarding universal proxy cards, changes to the Delaware General Corporation Law (the "DGCL"), and a periodic review of corporate governance matters
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Sep 23
Departure of Directors or Certain Officers
8:38am
of the Board’s nominating and corporate governance committee.
Ms. Zimmermann, 55, has been Senior Vice President and Head of Regulatory Affairs and R&D
8-K
x3wf144w0ou
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
8-K
c19v0pd01 vrnxa
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K
EX-3.1
yfi2imxolc8p
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-2.1
bmtuil4f7dloqpqhz233
13 Oct 20
Entry into a Material Definitive Agreement
8:44am